Kolexia
Declercq Pierre-Louis
Pneumologie
Centre Hospitalier de Dieppe
Dieppe, France
48 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Insuffisance respiratoire Pneumopathie infectieuse Choc Syndrome de détresse respiratoire de l'adulte Lésion pulmonaire aigüe Syndrome de détresse respiratoire du nouveau-né Maladie grave Choc septique

Industries

Schlesinger Group France
2 collaboration(s)
Dernière en 2022
B3TSI
1 collaboration(s)
Dernière en 2023
Pfizer
1 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

ROX index performance to predict high-flow nasal oxygen outcome in Covid-19 related hypoxemic acute respiratory failure.
Annals of intensive care   18 janvier 2024
Correction: Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study.
Intensive care medicine   05 novembre 2023
RECOVIDS: Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
Essai Clinique (CHU Dijon-Bourgogne)   11 septembre 2023
Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study.
Intensive care medicine   24 août 2023
Pneumopathie sévère a SARS-CoV-2: aspects TDM à 6 mois
Journal d'imagerie diagnostique et interventionnelle   29 mai 2023
HyperBetashock: Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility: an Open Label Prospective Randomized Study
Essai Clinique (CHU Amiens-Picardie)   09 février 2023
VITAKI: Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock? A Multicenter Randomized Controlled Study
Essai Clinique (CHU Amiens-Picardie)   08 décembre 2022
Influence of socioeconomic status on functional recovery after ARDS caused by SARS-CoV-2: a multicentre, observational study.
BMJ open   22 avril 2022
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial.
The Lancet. Respiratory medicine   11 novembre 2021
ICAR: Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Essai Clinique (Laboratoire français de Fractionnement et de Biotechnologies)   14 août 2021